Roflumilast

Cat. No.: PI162401323

Description: Roflumilast is the first approved phosphodiesterase 4 inhibitor (PDE-4 inhibitor). These enzymes come in increased amounts in the lungs and have an anti-inflammatory effect. It is used in the long-term therapy of severe COPD.

Product Details

CAS	162401-32-3
Molecular Formula	C17H14Cl2F2N2O3
Molecular Weight	403.21
Product Status	Commercial
Uses	Drugs for obstructive airway diseases
Molecular Size	Small
Controlled Substance	No

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *

For product and service inquiries, please use our online system or send an email to .